Myriad Genetics | MYGN - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Agilent USD 39.08B 6.43B 2026-06
Becton, Dickinson and Co. USD 61.93B 13.17B 2026-11
Bio-Rad Laboratories USD 8.71B 840M 2026-11
Bruker USD 9.68B 181M 2026-11
Danaher USD 157.81B 18.96B 2026-09
Illumina USD 37.12B 3.64B 2026-11
J&J USD 653.61B 42.25B 2026-09
Mettler Toledo International USD 36.07B 5.79B 2026-11
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Quest Diagnostics USD 25.72B 2.26B 2026-09
Quidel USD 942M 192M 2026-11
Repligen USD 9.74B 1.1B 2026-11
Revvity USD 19.52B 2.61B 2026-11
Standard Biotools USD 227M 95M 2026-11
Thermo Fisher Scientific USD 249.58B 58.93B 2026-09
Veracyte USD 4.12B 414M 2026-11
Waters USD 27.52B 14.26B 2026-11